Fierce Pharma

Merck KGaA lands FDA nod in rare tumor disorder, portending Ono, Daiichi showdown

Merck KGaA just secured an FDA approval for its new once-daily oral colony stimulating factor-1 receptor (CSF-1R) inhibitor, ...
financialcontent

FDA Approves PIMJETMI® (pimicotinib) for Patients with Tenosynovial Giant Cell Tumor

PIMJETMI (pimicotinib) is a prescription medicine used to treat adults with symptomatic tenosynovial giant cell tumor (TGCT) when surgery may make the symptoms worse or cause severe problems. It is ...

Central Valley Today – Springworks Therapeutics

Central Valley Today is joined by Sandra Miller, a patient advocate living with Desmoid Tumors, and Dr. Noah Federman, a ...
Wall Street Journal

The Wall Street Journal

Use Alt + Down Arrow to expand. Nasdaq futures rose nearly 2% after cloud-computing company CoreWeave’s results eased investors’ fears about the AI trade. GOP leaders blocked the move. House Democrats ...